BioSpace News Archive

2 Underappreciated Biotech Stocks to Buy in 2018

A look at two biopharma companies that fall into this category that investors should check out.

January 2, 2018
·
2 min read
·
Mark Terry
Biotech Bay

PEAR Therapeutics Scores $50M in Series B Funding Round

The funds raised will be used to further commercialize reSET and its pipeline and platform.

January 2, 2018
·
2 min read
·
Mark Terry
Deals

3 Biotechs Seeking $271M IPO in the New Year

Three biotech companies want to start out the new year with a new start.

January 2, 2018
·
2 min read
·
Mark Terry
Deals

Siemens to Test Interest of State Funds in Healthineers IPO

The listing of a minority of the unit, which makes X-ray and MRI machines, is set to take place in the first half of 2018.

January 2, 2018
·
1 min read
Genetown

Former Pfizer CEO’s Boston Startup Centrexion Lands $67M for Ph3 Osteoarthritis Pain Drug

Centrexion closed on a Series D financing worth $67M to develop its knee osteoarthritis drug in Phase III.

January 2, 2018
·
2 min read
·
Mark Terry
Laviana Pharma Closes $15M Financing for China CRO/CMO Services

Laviana Pharma closed a $15M Series B funding led by Shenzhen Huayi Capital.

January 2, 2018
·
1 min read
Genetown

5 Massachusetts Biotechs That Tanked More Than 60% in 2017

This is definitely a list few, if any, companies want to be on.

January 2, 2018
·
3 min read
·
Mark Terry
Week in Review: 2017 Was Record Investment Year for China Life Science; Final Week Adds $669M

Shanghai’s SARI was the lead investor in a $359M acquisition of a 90% interest in Group NMS, a Milan oncology biopharma with CRO operations.

January 2, 2018
·
1 min read
Policy

Arrogance and Greed: Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit

From around 2014 through 2016, Valeant seemingly had a crisis story per week, ranging from insider trading to channel stuffing

January 2, 2018
·
2 min read
·
Mark Terry
Biotech Bay

23AndMe Launches Massive Study on How Genes Affect Weight Loss

The company announced the study in a blog post on its website.

January 2, 2018
·
1 min read